Evidence map›Paper›PMID 40547510›Full record

ArticleJournal of experimental pharmacology2025

Deshanda Kurniawan Prayoga, Diah Lia Aulifa, Arif Budiman, Jutti Levita, Supat Jiranusornkul

Abstract read
In one paragraph

Article in Journal of experimental pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. International journal of molecular sciences · 2026
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Deshanda Kurniawan Prayoga *Doctoral Program in Pharmacy, Faculty of Pharmacy, Padjadjaran University, Sumedang, West Java, Indonesia.
Diah Lia Aulifa *Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Padjadjaran University, Sumedang, Indonesia.
Arif Budiman *Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Padjadjaran University, Sumedang, Indonesia.
Jutti Levita *Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Padjadjaran University, Sumedang, Indonesia.ORCID 0000-0002-4578-4174
Supat Jiranusornkul *Department of Pharmaceutical Science, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ethanol consumption by oral route can induce gastric cell necrosis and vascular damage due to excessive reactive oxygen species (ROS) production. ROS activates the translocation of NF-κB to the nucleus and increases iNOS expression, an enzyme that catalyzes nitric oxide (NO) production, eventually disrupting gastric protective mechanisms and contributing to ulcer formation. Purpose: To confirm the gastro-protective and anti-ulcer effects of the Methods: The fresh inflorescence petals were collected from West Java, Indonesia, and were extracted using 70% ethanol. The effects of 5 days of oral administration of EEIE were studied in ethanol-induced adult male Wistar rats by examining the weight gain percentage, feed residue, stomach ratio index, and microscopic and macroscopic evaluation of gastric mucosal damage. Subsequently, the iNOS expression in the rats' stomach was Western blotted by employing β-actin as the loading control. Results: EEIE reduced weight gain percentage but did not show a significant difference in feed residue. EEIE increased the stomach ratio index, and at a dose of 625 mg/kg BW, significantly reduced the ulcer index, providing 100% protection (p < 0.05) to rats while decreasing inflammatory cell infiltration. EEIE inhibited the expression of iNOS in both cleaved and full-length forms at this dose. Conclusion:

Indexed as

acute inflammationetlingeragastric ulcersiNOSmedicinal plantszingiberaceae

Identifiers

PMID40547510
PMCPMC12182249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.